ANDREY, Dmytrenko

Metadatos

Mostrar el registro completo del ítem

Licencia de uso del documento

ANDREY, Dmytrenko
Centre d'Etudes Nucléaires de Bordeaux Gradignan [CENBG]

Idioma

Autre document

Este ítem está publicado en

2013-11-26

Resumen en inglés

A tangible compound repository is a very important source of exclusive organic molecules for screening projects in drug discovery. Tangible compounds denote molecules that are chemically feasible and having a high likelihood of being synthesized. Typically these are compounds that can be produced with synthetic schemes that have been validated. OTAVA Ltd. offers a collection of novel Tangible Screening Compounds including about 500,000 structures. The novel screening compounds ordered from this collection could be individually synthesized and delivered within 4 weeks. The compounds' purity is not less than 90% which can be validated by several methods: NMR and GC/LC/MS. NMR spectra are available upon request. Packaging of ordered compounds can be done in deep-well plates or bar-coded vials, weighing out is free. Tangible Screening Compounds from OTAVA is a unique opportunity to enrich your company's screening collection with molecules which are not available from other vendors. More information about OTAVA's novel screening compounds you can find at the web-site www.otavachemicals.com.< Leer menos

Palabras clave en inglés

Tangible Screening Compounds

drug discovery

organic molecules

Orígen

Importado de Hal

Centros de investigación

Centre d'Études Nucléaires de Bordeaux Gradignan (CENBG)